MedEnvision orthopaedic surgery efficiency solutions, including its Gripper and EsySuit medical technology products.
TA Associates will become the majority shareholder in Belgian orthopaedic technology company MedEnvision, alongside existing investor Smile Invest and the company's management. The transaction is expected to close in Q4 2026.

Global private equity firm TA Associates has agreed to acquire a majority stake in MedEnvision, a Belgium-based medical technology company developing solutions to improve efficiency in orthopaedic surgery.

The transaction, announced on October 22, 2026, will bring TA Associates into the company alongside its founders, CEO Dries Goyens, management team and existing financial partner Smile Invest. Financial terms were not disclosed.

The deal is expected to close in the fourth quarter of 2026, subject to customary closing conditions.

Founded in 2012 and headquartered in Westerlo, Belgium, MedEnvision develops products that help surgical teams standardise operating theatre workflows. Its Efficient Surgery (ESY) solution incorporates the Gripper and EsySuit products, which support key steps in hip, knee and shoulder replacement procedures.

The company designs its solutions to help hospitals improve operating room efficiency, reduce procedural costs, optimise staffing, improve ergonomics and support infection control. Its products are used in more than 26 countries, and the company also operates a subsidiary in the United States.

The investment partnership will support MedEnvision’s international expansion strategy, including further penetration of the US healthcare market. The company also plans to broaden its product portfolio and expand its commercial organisation.

Smile Invest, which partnered with MedEnvision in 2024, will remain involved alongside TA Associates and the company’s existing leadership. The new ownership arrangement is intended to support MedEnvision’s continued product development and expansion into additional markets.

TA Associates invests in companies across healthcare, technology, business services and financial services. The MedEnvision transaction adds an orthopaedic surgical technology business to its healthcare investment activities.

Get the latest startup funding news in your inbox.

We don’t spam! Read our privacy policy for more info.

Share